tRNA Deregulation and Its Consequences in Cancer

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• Transfer RNA (tRNA) expression is frequently deregulated in cancer cells.
• The mechanisms and functional significance of tRNA deregulation in cancer are not well understood.
• The diversity of the cancer cell proteome, which is not fully explained by the transcriptome alone, suggests a role for post-transcriptional regulation.

Purpose of the Study:

• To review evidence supporting the hypothesis that tRNA deregulation and altered translational error rates contribute to cancer biology.
• To explore the functional implications of tRNA dysregulation in tumor proteome diversity, heterogeneity, genome instability, and drug resistance.

Main Methods:

• Literature review of existing studies on tRNA expression, mRNA translation, and cancer.
• Analysis of data from various model organisms investigating translational errors and their adaptive roles.
• Synthesis of findings to support a unifying hypothesis on tRNA deregulation in cancer.

Main Results:

• Evidence suggests tRNA expression deregulation is linked to increased translational error rates in tumors.
• Elevated translational error rates can diversify the proteome and contribute to cell population heterogeneity.
• These alterations are associated with genome instability and acquired drug resistance in cancer cells.

Conclusions:

• TRNA deregulation and associated translational errors are proposed as key drivers of proteome diversity and key contributors to cancer progression.
• Adaptive mistranslation and tRNA-mediated gene expression control offer novel insights into tumor adaptation.
• Targeting tRNA biology and translational fidelity presents potential therapeutic strategies for cancer treatment.